JG
AVEO

Jefferies Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Jefferies Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,221
Closed -$116K – 2799
2018
Q4 		$116K Buy
+7,221
New +$159K ﹤0.01% 1943
2018
Q2 		– Sell
-1,000
Closed -$29K – 2842
2018
Q1 		$29K Buy
+1,000
New +$29.3K ﹤0.01% 2150

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jefferies Group's AVEO Position: Q1 2019 in Review

Jefferies Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 7,221 shares — an estimated $116K sold.

Jefferies Group first reported a position in AVEO in Q1 2018 and held it in 2 quarters. The position peaked at $116K in Q4 2018. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

  • Jefferies Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Jefferies Group sold 7,221 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $116K.
  • Jefferies Group first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2018 and held it in 2 quarters.
  • Jefferies Group's AVEO Pharmaceuticals, Inc. position peaked at $116K in Q4 2018.
  • 83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on Jefferies Group's 13F filing for Q1 2019, filed 15 May 2019.